Online ISSN: 3007-0244,
Print ISSN:  2410-4280
Introduction. Heart failure (HF) is a significant public health problem, especially in the context of increasing life expectancy and an aging population. Data provided by the European Society of Cardiology shows a median prevalence of HF in 2019 of 17 cases per 1,000 people, with differences across countries. There is also an increase in the number of cases of cardiovascular diseases in Kazakhstan. Aim. To analyze the incidence of diseases and the death rate from chronic heart failure (CHF) in the city of Almaty. Materials and methods. A retrospective study was conducted. We analyzed the incidence and mortality from CHF in Almaty from 2013 to 2022 based on data provided by the National Scientific Center for Health Development, a branch in Almaty. CHF mortality was predicted for the next five years using the TREND function in Excel. We also used a natural logarithmic linear model to analyze the constant percentage change in velocity over time. A p value of less than 0.05 is considered statistically significant. Results. A study of the incidence and mortality from CHF in Almaty from 2013 to 2023 revealed an increase in the incidence from 9885 to 15332 cases, reaching a peak decrease in 2015 to 7748. While the death rate decreased from 6.5 to 3.0 per 100,000 population. The forecast for the next five years shows the likelihood of a further increase in morbidity. The number of patients registered at the dispensary with congestive heart failure has increased from 232 to 7160, and further growth is expected by 2027. There is also an increase in treated cases. Conclusion. A further increase in the incidence and mortality from CHF is predicted in the next five years, which underscores the need to implement cardiorehabilitation programs involving multidisciplinary teams and patient-centered care principles to improve the quality of life of patients with CHF. Working to reduce risk factors such as alcohol consumption, smoking, and improved nutrition, with the participation of all stakeholders, contributes to improving performance.
Anuar Akhmetzhan1, Nursultan Zhakyp1, Kamilla Fayzullina1, Diana Dosbayeva2, Nazgul Akhtaeva1, Aziza Imamatdinova1, 1 Asfendiyarov Kazakh National Medical University, Almaty, Republic of Kazakhstan; 2 Kazakhstans Medical University “KSPH”, Almaty, Republic of Kazakhstan.
1. Bellanca L., Linden S., Farmer R. Incidence and prevalence of heart failure in England: a descriptive analysis of linked primary and secondary care data - the PULSE study. BMC Cardiovasc Disord. 2023 Jul 26; 23(1):374. doi: 10.1186/s12872-023-03337-1. 2. Chou P.L., Lin P.C., Lin C.C., Lee H.C., Huang Y.T. Trends and Changes in Intensive Care Use for Patients with Heart Failure in the Last Month of Life. Inquiry. 2024 Jan-Dec; 61:469580241239143. doi: 10.1177/00469580241239143. 3. Coats A.J.S. Ageing, demographics, and heart failure. Eur Heart J Suppl. 2019 Dec;21(Suppl L):L4-L7. doi: 10.1093/eurheartj/suz235. Epub 2019 Dec 23. 4. Cook C., Cole G., Asaria P., Jabbour R., Francis D.P. The annual global economic burden of heart failure. Int J Cardiol. 2014 Feb 15;171(3):368-76. doi: 10.1016/j.ijcard.2013.12.028. Epub 2013 Dec 22. 5. Diseases Management Programs Development and Implementation Implementation completion and results report 4883-KZ, Report No: ICR00003816, December 28, 2017, 6. Dunlay S.M., Roger V.L., Redfield M.M. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017 Oct;14(10):591-602. doi: 10.1038/nrcardio.2017.65. Epub 2017 May 11. 7. Janssen D.J.A., Johnson M.J., Spruit M.A. Palliative care needs assessment in chronic heart failure. Curr Opin Support Palliat Care. 2018 Mar;12(1):25-31. doi: 10.1097/SPC.0000000000000317. 8. Jauho M. The North Karelia Project (1972-1997) and the Origins of the Community Approach to Cardiovascular Disease Prevention. Am J Public Health. 2021 May; 111(5):890-895. doi: 10.2105/AJPH.2020.306016. Epub 2021 Mar 18. 9. Junusbekova G., Tundybayeva M., Akhtaeva N., Kosherbayeva L. Recent Trends in Cardiovascular Disease Mortality in Kazakhstan. Vasc Health Risk Manag. 2023 Aug 23;19:519-526. doi: 10.2147/VHRM.S417693. 10. Isath A., Malik A., Bandyopadhyay D., Goel A., Hajra A., Dhand A., Lanier G.M., Fonarow G.C., Lavie C.J., Gass A.L. COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis. Curr Probl Cardiol. 2023 Apr;48(4):101541. doi: 10.1016/j.cpcardiol.2022.101541. 11. Linden S., Gollop N.D., Farmer R. Resource utilisation and outcomes of people with heart failure in England: a descriptive analysis of linked primary and secondary care data - the PULSE study. Open Heart. 2023 Dec 9;10(2):e002467. doi: 10.1136/openhrt-2023-002467. 12. Mukasheva G., Abenova M., Shaltynov A., Tsigengage O., Mussabekova Z., Bulegenov T., Shalgumbaeva G., Semenova Y. Incidence and Mortality of Cardiovascular Disease in the Republic of Kazakhstan: 2004-2017. Iran J Public Health. 2022 Apr;51(4):821-830. doi: 10.18502/ijph.v51i4.9243 13. Niessen L.W., Squire S.B. Universal health coverage and chronic conditions. Lancet Glob Health. 2019 Oct;7(10):e1290-e1292. doi: 10.1016/S2214-109X(19)30366-3. Epub 2019 Aug 30. 14. Ong S.C., Low J.Z. Financial burden of heart failure in Malaysia: A perspective from the public healthcare system. PLoS One. 2023 Jul 5;18(7):e0288035. doi: 10.1371/journal.pone.0288035. 15. Reyes EB, Ha JW, Firdaus I et al. Heart failure across Asia: same healthcare burden but differences in organization of care. Int J Cardiol. 2016; 223:163–7. doi: 10.1016/j.ijcard.2016.07.256. 16. Savarese G., Becher P.M., Lund L.H., Seferovic P., Rosano G.M.C., Coats A.J.S. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023 Jan 18;118(17):3272-3287. doi: 10.1093/cvr/cvac013. Erratum in: Cardiovasc Res. 2023 Jun 13;119(6):1453. 17. Seferovic P.M., Vardas P., Jankowska E.A. et al. The Heart Failure Association atlas: heart failure epidemiology and management statistics 2019. Eur J Heart Fail. 2021;23:906–14. doi: 10.1002/ejhf.2143 18. Shafie A.A., Tan Y.P., Ng C.H. Systematic review of economic burden of heart failure. Heart Fail Rev. 2018 Jan;23(1):131-145. doi: 10.1007/s10741-017-9661-0. 19. Shrestha J., Done S. An overview of chronic heart failure. Nurs Stand. 2023 Aug 2;38(8):43-49. doi: 10.7748/ns.2023.e12049. Epub 2023 Jul 3. 20. The Center for Primary Health Care of the World Health Organization (Kazakhstan) 21. Tsao C.W., Lyass A., Enserro D., Larson M.G., Ho J.E., Kizer J.R., Gottdiener J.S., Psaty B.M., Vasan R.S. Temporal Trends in the Incidence of and Mortality Associated With Heart Failure With Preserved and Reduced Ejection Fraction. JACC Heart Fail. 2018 Aug;6(8):678-685. doi: 10.1016/j.jchf.2018.03.006. Epub 2018 Jul 11. 22. Virani S.S., Alonso A., Aparicio H.J. et al. Heart disease and stroke statistics – 2021 update: a report from the American Heart Association. Circulation. 2021; 143:e254–743. doi:10.1161/CIR.0000000000000950.
Количество просмотров: 143

Ключевые слова: heart failure, cardiovascular diseases, morbidity, mortality.

Библиографическая ссылка

Akhmetzhan A., Zhakyp N., Fayzullina K., Dosbayeva D., Akhtaeva N., Imamatdinova A. Trends in morbidity and mortality from chronic heart failure in Almaty // Nauka i Zdravookhranenie [Science & Healthcare]. 2024. Vol.26 (2). pp. 53-59. doi 10.34689/SH.2024.26.2.007

Авторизируйтесь для отправки комментариев